TY - JOUR
T1 - Case Report
T2 - A case of transcatheter aortic valve replacement in a patient with a small aortic annulus using the Acurate Neo2
AU - Malik, Shahzil Abdur Rehman
AU - Ali, Jamshed
AU - Javed, Maleeha
AU - Hussain, Kamran
AU - Azeem, Navaira
AU - Rehman, Nasir
AU - Faheem, Osman
N1 - Publisher Copyright:
2025 Malik, Ali, Javed, Hussain, Azeem, Rehman and Faheem.
PY - 2025
Y1 - 2025
N2 - Small aortic annulus poses a major challenge in aortic valve replacement due to the increased risk of prosthesis–patient mismatch (PPM) and increased surgical risk. In recent years, transcatheter aortic valve replacement (TAVR) has emerged as a popular alternative to the traditional surgical aortic valve replacement. We present the case of an 80-year-old woman with a small aortic annulus who underwent TAVR using a self-expanding transcatheter heart valve Acurate Neo2 after an non-ST-segment elevation myocardial infarction (NSTEMI) presentation. These risks, combined with advanced age, significant co-morbidities, and a severely calcified small aortic annulus, supported the choice of TAVR with a self-expanding Acurate Neo2 valve. Despite multiple risk factors for PPM, the patient had a successful outcome without major complications. Our case highlights the off-label use of the Acurate Neo2 valve in one of the smallest aortic annuli reported to date, showcasing its feasibility in Asian and resource-limited settings.
AB - Small aortic annulus poses a major challenge in aortic valve replacement due to the increased risk of prosthesis–patient mismatch (PPM) and increased surgical risk. In recent years, transcatheter aortic valve replacement (TAVR) has emerged as a popular alternative to the traditional surgical aortic valve replacement. We present the case of an 80-year-old woman with a small aortic annulus who underwent TAVR using a self-expanding transcatheter heart valve Acurate Neo2 after an non-ST-segment elevation myocardial infarction (NSTEMI) presentation. These risks, combined with advanced age, significant co-morbidities, and a severely calcified small aortic annulus, supported the choice of TAVR with a self-expanding Acurate Neo2 valve. Despite multiple risk factors for PPM, the patient had a successful outcome without major complications. Our case highlights the off-label use of the Acurate Neo2 valve in one of the smallest aortic annuli reported to date, showcasing its feasibility in Asian and resource-limited settings.
KW - case report
KW - prosthesis-patient mismatch
KW - resource limited settings
KW - self-expanding transcatheter heart valves
KW - small aortic annulus
UR - https://www.scopus.com/pages/publications/85218253521
U2 - 10.3389/fcvm.2025.1513802
DO - 10.3389/fcvm.2025.1513802
M3 - Article
AN - SCOPUS:85218253521
SN - 2297-055X
VL - 12
JO - Frontiers in Cardiovascular Medicine
JF - Frontiers in Cardiovascular Medicine
M1 - 1513802
ER -